TNF and rheumatoid arthritis: Our findings show that the use of b-DMARDs as first-line include anti-TNF therapies, mostly as monotherapy, although a recent meta-analysis has clearly demonstrated that combining methotrexate with biological drug therapy in early RA achieved significantly better results.[27]